Sign Up to like & get
recommendations!
0
Published in 2021 at "Clinical and Experimental Nephrology"
DOI: 10.1007/s10157-021-02155-z
Abstract: Patients on maintenance hemodialysis (HD) generally require management of hyperphosphatemia and take phosphate binders (PBs) such as ferric citrate (FC) and lanthanum carbonate (LC) [1]. Meanwhile, many HD patients require antacid therapy (AAT). Although PBs…
read more here.
Keywords:
lc250;
phosphate binders;
aat;
efficacy ... See more keywords